ACH-0143102

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACH-0143102, covering 2014-10-03 to 2014-10-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Safety, Tolerability, and Antiviral Activity of ACH-0143102 Plus Ribavirin In Treatment-naive Hepatitis C Virus Infection Genotype 1b Participants [Phase 1]

See pricing